Diagnostic Guidance for C. difficile Infections
- 5 January 2024
- book chapter
- Published by Springer Nature
- Vol. 1435, 33-56
Abstract
Diagnosis of Clostridioides difficile infection (CDI) can be challenging. First of all, there has been debate on which of the two reference assays, cell cytotoxicity neutralization assay (CCNA) or toxigenic culture (TC), should be considered the gold standard for CDI detection. Although the CCNA suffers most from suboptimal storage conditions and subsequent toxin degradation, TC is reported to falsely increase CDI detection rates as it cannot differentiate CDI patients from patients asymptomatically colonised by toxigenic C. difficile. Several rapid assays are available for CDI detection and fall into three broad categories: (1) enzyme immunoassays for glutamate dehydrogenase, (2) enzyme immunoassays or single-molecule array assays for toxins A/B and (3) nucleic acid amplification tests detecting toxin genes. All three categories have their own limitations, being suboptimal specificity and/or sensitivity or the inability to discern colonised patients from CDI patients. In light of these limitations, multi-step algorithmic testing has been advocated by international guidelines (IDSA/SHEA and ESCMID) in order to optimize diagnostic accuracy. As a result, a survey performed in 2018–2019 in Europe revealed that most of all hospital sites reported using more than one test to diagnose CDI. CDI incidence rates are also influenced by sample selection criteria, as several studies have shown that if not all unformed stool samples are tested for CDI, many cases may be missed due to an absence of clinical suspicion. Since methods for diagnosing CDI remain imperfect, there has been a growing interest in alternative testing strategies like faecal microbiota biomarkers, immune modulating interleukins, cytokines and imaging methods. At the moment, these alternative methods might play an adjunctive role, but they are not suitable to replace conventional CDI testing strategies.Keywords
This publication has 113 references indexed in Scilit:
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionThe Lancet Infectious Diseases, 2013
- Impact of Change to Molecular Testing for Clostridium difficile Infection on Healthcare Facility–Associated Incidence RatesInfection Control & Hospital Epidemiology, 2013
- Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- An Evaluation of Repeat Stool Testing for Clostridium difficile Infection by Polymerase Chain ReactionJournal of Clinical Gastroenterology, 2012
- Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?European Journal of Clinical Microbiology & Infectious Diseases, 2012
- Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test ResultsJournal of Clinical Microbiology, 2012
- Is Repeat PCR Needed for Diagnosis of Clostridium difficile Infection?Journal of Clinical Microbiology, 2010
- Nonutility of Repeat Laboratory Testing for Detection of Clostridium difficile by Use of PCR or Enzyme ImmunoassayJournal of Clinical Microbiology, 2008
- Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile : Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphism, and Surface Layer Protein A Gene Sequence TypingJournal of Clinical Microbiology, 2008
- Typing and Subtyping of Clostridium difficile Isolates by Using Multiple-Locus Variable-Number Tandem-Repeat AnalysisJournal of Clinical Microbiology, 2007